Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
1
0
0
0
MIND MEDICINE (MINDMED) Share · CA60255C8850 · MNMD (XTSE) United States · Healthcare — real-time prices and quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of MIND MEDICINE (MINDMED)
Analyst Grade Summary
No Price
Share Float & Liquidity
Free Float 97,20 %
Shares Float 73,44 M
Shares Outstanding 75,55 M
Company Profile for MIND MEDICINE (MINDMED) Share
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology. The company develops MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder, as well as for the treatment of chronic pain; and MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal. It also develops MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. The company is headquartered in New York, New York.
Company Data
Name MIND MEDICINE (MINDMED)
Company Mind Medicine (MindMed) Inc.
Symbol MNMD
Website
https://www.mindmed.co
Primary Exchange 
TSX
TSX
ISIN CA60255C8850
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Robert Barrow
Market Capitalization 1 Mrd.
Country United States
Currency CAD
Employees 0,1 T
Address One World Trade Center, 10007 New York City
IPO Date 2020-03-03
Key Ratios
Valuation
P/E Ratio -8,28x
P/B Ratio 8,07x
P/S Ratio —
P/FCF Ratio -8,97x
Margins
Gross Margin —
Operating Margin —
Net Margin —
As of 28.07.2026
Stock Splits
| Date | Split |
|---|---|
| 29.08.2022 | 1:15 |
Ticker Symbols
| Name | Symbol |
|---|---|
| Düsseldorf | MMMMIR50.DUSB |
| Frankfurt | MMQ.F |
| Hamburg | MMMMIR50.HAMB |
| NASDAQ | MNMD |
| Quotrix | MMMMIR50.DUSD |
More Shares
Investors who hold MIND MEDICINE (MINDMED) also have the following shares in their portfolio:
